The purpose is to study the effect of individualized nutritional counselling compared to usual nutritional care on cross-sectional muscle area in patients with stage IV colorectal cancer during first line chemotherapy. Secondary, effect on total lean body mass, treatment intensity, physical functioning, quality of life and survival will be studied.We hypothesize that patients in the intervention arm benefit from individualized nutritional counseling.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
107
Patients in the intervention-arm will receive individualized nutritional counseling by a registered dietitian during standard treatment with chemotherapy. The main goals of the nutritional intervention will be to enable every patient to achieve sufficient protein and energy intake with attention for sufficient intake of micronutrients and a sufficient physical activity level.
VU Medical Center
Amsterdam, Netherlands
Amphia Hospital
Breda, Netherlands
Reinier de Graaf
Delft, Netherlands
Ziekenhuis Gelderse Vallei
Ede, Netherlands
Spaarne hospital
Change in skeletal muscle area (cm2) between individualized nutritional counselling versus usual nutritional care
will be measured with SliceOmatic software V5.0 (Tomovision) with use of routinely conducted CT scans for diagnostic and disease evaluation purposes
Time frame: During 9 weeks of first line chemotherapy
Change in total body lean body mass and segmental lean body mass (DEXA) in patients with stage IV colorectal cancer during 9 weeks of first line chemotherapy between individualized nutritional counseling versus usual nutritional care
Time frame: During 9 weeks of first line chemotherapy
Change in skeletal muscle area in patients with stage IV colorectal cancer during 20 weeks of first line chemotherapy between individualized nutritional counseling.versus usual nutritional care.
Change in skeletal muscle area (cm2) between individualized nutritional counselling versus usual nutritional care
Time frame: During 20 weeks of first line chemotherapy
Composite of treatment toxicity, treatment intensity, treatment outcome, survival, physical functioning, quality of life and hand grip strength of both study arms
Time frame: During 9 weeks and during 20 weeks of first line chemotherapy
Associations of (changes in) muscle area with (changes in) mid-upper arm muscle circumference, whole body fat free mass (BIA) and whole body lean body mass (DEXA).
Time frame: During 9 weeks of first line chemotherapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Hoofddorp, Netherlands